0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.74%
Positive revenue growth while 0335.HK is negative. John Neff might see a notable competitive edge here.
44.00%
Positive gross profit growth while 0335.HK is negative. John Neff would see a clear operational edge over the competitor.
175.08%
Positive EBIT growth while 0335.HK is negative. John Neff might see a substantial edge in operational management.
175.08%
Operating income growth above 1.5x 0335.HK's 60.82%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
228.07%
Net income growth of 228.07% while 0335.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
228.28%
EPS growth of 228.28% while 0335.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
228.28%
Diluted EPS growth under 50% of 0335.HK's 3725.03%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.00%
Slight or no buybacks while 0335.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.00%
Reduced diluted shares while 0335.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-99.98%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-63.53%
Negative OCF growth while 0335.HK is at 69.98%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-57.45%
Negative FCF growth while 0335.HK is at 69.44%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-51.09%
Negative 10Y revenue/share CAGR while 0335.HK stands at 76.49%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.87%
5Y revenue/share CAGR under 50% of 0335.HK's 74.31%. Michael Burry would suspect a significant competitive gap or product weakness.
-51.44%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-2256.08%
Negative 10Y OCF/share CAGR while 0335.HK stands at 138.59%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-2477.32%
Negative 5Y OCF/share CAGR while 0335.HK is at 58.28%. Joel Greenblatt would question the firm’s operational model or cost structure.
5.55%
3Y OCF/share CAGR under 50% of 0335.HK's 54.72%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-9.39%
Negative 10Y net income/share CAGR while 0335.HK is at 1682.63%. Joel Greenblatt sees a major red flag in long-term profit erosion.
37.21%
Below 50% of 0335.HK's 2011.73%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
153.00%
3Y net income/share CAGR above 1.5x 0335.HK's 0.02%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
65.53%
10Y equity/share CAGR at 50-75% of 0335.HK's 105.77%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
71.18%
5Y equity/share CAGR above 1.5x 0335.HK's 10.86%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-9.27%
Negative 3Y equity/share growth while 0335.HK is at 4.89%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-99.92%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
-99.99%
Negative near-term dividend growth while 0335.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.71%
AR growth of 9.71% while 0335.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-1.97%
Inventory is declining while 0335.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.97%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
6.25%
BV/share growth above 1.5x 0335.HK's 2.36%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-16.11%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-32.73%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.50%
We cut SG&A while 0335.HK invests at 80.49%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.